CoChat
Sign Up
Cited by 28

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Remyelination in multiple sclerosis from the miRNA perspective

Maciak, Karina, Dziedzic, Angela, Saluk, Joanna·2023·Frontiers in Molecular Neuroscience
DOI 10.3389/fnmol.2023.1199313PMC PMC10270307
Open this paper in CoChat — free account

Abstract

Remyelination relies on the repair of damaged myelin sheaths, involving microglia cells, oligodendrocyte precursor cells (OPCs), and mature oligodendrocytes. This process drives the pathophysiology of autoimmune chronic disease of the central nervous system (CNS), multiple sclerosis (MS), leading to nerve cell damage and progressive neurodegeneration. Stimulating the reconstruction of damaged myelin sheaths is one of the goals in terms of delaying the progression of MS symptoms and preventing neuronal damage. Short, noncoding RNA molecules, microRNAs (miRNAs), responsible for regulating gene expression, are believed to play a crucial role in the remyelination process. For example, studies showed that miR-223 promotes efficient activation and phagocytosis of myelin debris by microglia, which is necessary for the initiation of remyelination. Meanwhile, miR-124 promotes the return of activated microglia to the quiescent state, while miR-204 and miR-219 promote the differentiation of mature oligodendrocytes. Furthermore, miR-138, miR-145, and miR-338 have been shown to be involved in the synthesis and assembly of myelin proteins. Various delivery systems, including extracellular vesicles, hold promise as an efficient and non-invasive way for providing miRNAs to stimulate remyelination. This article summarizes the biology of remyelination as well as current challenges and strategies for miRNA molecules in potential diagnostic and therapeutic applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnmol.2023.1199313

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Summary of the miRNAs associated with different phases of the remyelination process. In the figure, miRNAs that have a positive impact on a particular stage of remyelination are shown in green, whereas miRNAs that have a negative effect on a particular stage of remyelination are shown in red. (A) Clearance of myelin debris and secreted of factors by microglia. (B) OPCs recruitment and proliferation. (C) OPCs differentiation and maturation. (D) Myelin proteins assembly. OPCs, Oligodendrocyte Precursor Cells (OPCs); OLs, oligodendrocytes.
Figure 1 Summary of the miRNAs associated with different phases of the remyelination process. In the figure, miRNAs that have a positive impact on a particular stage of remyelination are shown in green, whereas miRNAs that have a negative effect on a particular stage of remyelination are shown in red. (A) Clearance of myelin debris and secreted of factors by microglia. (B) OPCs recruitment and proliferation. (C) OPCs differentiation and maturation. (D) Myelin proteins assembly. OPCs, Oligodendrocyte Precursor Cells (OPCs); OLs, oligodendrocytes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 111

  1. Aparicio, 2013, The notch signaling pathway: its role in focal CNS demyelination and apotransferrin-induced remyelination, J. Neurochem., 127, 819, 10.1111/jnc.12440 · DOI
  2. Arranz, 2010, Environmental enrichment improves age-related immune system impairment: long-term exposure since adulthood increases life span in mice, Rejuvenation Res., 13, 415, 10.1089/rej.2009.0989 · DOI
  3. Billinghurst, 1998, Remyelination: cellular and gene therapy, Semin. Pediatr. Neurol., 5, 211, 10.1016/s1071-9091(98)80036-3 · DOI
  4. Birmpili, 2022, The translatability of multiple sclerosis animal models for biomarkers discovery and their clinical use, Int. J. Mol. Sci., 23, 11532, 10.3390/ijms231911532 · DOI
  5. Bottes, 2021, Live imaging of remyelination in the adult mouse corpus callosum, Proc. Natl. Acad. Sci., 118, e2025795118, 10.1073/pnas.2025795118 · DOI
  6. Brandi, 2021, Nerve growth factor neutralization promotes oligodendrogenesis by increasing miR-219a-5p levels, Cells, 10, 405, 10.3390/cells10020405 · DOI
  7. Bruinsma, 2017, Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS, J. Neuroinflammation, 14, 235, 10.1186/s12974-017-1006-3 · DOI
  8. Chari, 2007, Remyelination in multiple sclerosis, Int. Rev. Neurobiol., 79, 589, 10.1016/S0074-7742(07)79026-8 · DOI
  9. Chen, 2021, Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits?, Open Biol., 11, 200352, 10.1098/rsob.200352 · DOI
  10. Diao, 2015, Nanofiber-mediated microRNA delivery to enhance differentiation and maturation of oligodendroglial precursor cells, J. Control. Release, 208, 85, 10.1016/j.jconrel.2015.03.005 · DOI
  11. Dolati, 2018, Dysregulated network of miRNAs involved in the pathogenesis of multiple sclerosis, Biomed. Pharmacother., 104, 280, 10.1016/j.biopha.2018.05.050 · DOI · Paper page
  12. Duffy, 2020, The role of MicroRNAs in repair processes in multiple sclerosis, Cells, 9, 1711, 10.3390/cells9071711 · DOI
  13. Dugas, 2010, Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination, Neuron, 65, 597, 10.1016/j.neuron.2010.01.027 · DOI · Paper page
  14. Dutta, 2013, Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors, Ann. Neurol., 73, 637, 10.1002/ana.23860 · DOI · Paper page
  15. Ebrahimkhani, 2017, Exosomal microRNA signatures in multiple sclerosis reflect disease status, Sci. Rep., 7, 14293, 10.1038/s41598-017-14301-3 · DOI
  16. Edgünlü, 2022, miR-181a-5p is a potential candidate epigenetic biomarker in multiple sclerosis, Genome, 65, 547, 10.1139/gen-2022-0040 · DOI · Paper page
  17. Engelhardt, 2005, The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms, Trends Immunol., 26, 485, 10.1016/j.it.2005.07.004 · DOI
  18. Fancy, 2009, Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS, Genes Dev., 23, 1571, 10.1101/gad.1806309 · DOI · Paper page
  19. Fang, 2023, A subset of OPCs do not express Olig2 during development which can be increased in the adult by brain injuries and complex motor learning, Glia, 71, 415, 10.1002/glia.24284 · DOI
  20. Fields, 2008, White matter in learning, cognition and psychiatric disorders, Trends Neurosci., 31, 361, 10.1016/j.tins.2008.04.001 · DOI · Paper page
  21. Filippi, 2018, Multiple sclerosis, Nat. Rev. Dis. Primers., 4, 1, 10.1038/s41572-018-0041-4 · DOI · Paper page
  22. Frischer, 2015, Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque, Ann. Neurol., 78, 710, 10.1002/ana.24497 · DOI · Paper page
  23. Fu, 2014, Phagocytosis of microglia in the central nervous system diseases, Mol. Neurobiol., 49, 1422, 10.1007/s12035-013-8620-6 · DOI
  24. Fujiwara, 2022, microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance, J. Clin. Invest., 132, e155693, 10.1172/JCI155693 · DOI
  25. Gaesser, 2016, Intracellular signaling pathway regulation of myelination and remyelination in the CNS, Exp. Neurol., 283, 501, 10.1016/j.expneurol.2016.03.008 · DOI
  26. Galloway, 2019, miR-223 promotes regenerative myeloid cell phenotype and function in the demyelinated central nervous system, Glia, 67, 857, 10.1002/glia.23576 · DOI · Paper page
  27. Galloway, 2022, Investigating the NLRP3 inflammasome and its regulator miR-223-3p in multiple sclerosis and experimental demyelination, J. Neurochem., 163, 94, 10.1111/jnc.15650 · DOI
  28. Gebert, 2019, Regulation of microRNA function in animals, Nat. Rev. Mol. Cell Biol., 20, 21, 10.1038/s41580-018-0045-7 · DOI · Paper page
  29. Gholami, 2020, Apamin administration impact on miR-219 and miR-155-3p expression in cuprizone induced multiple sclerosis model, Mol. Biol. Rep., 47, 9013, 10.1007/s11033-020-05959-6 · DOI · Paper page
  30. Goldenberg, 2012, Multiple sclerosis review, P T, 37, 175
  31. Goldschmidt, 2009, Remyelination capacity of the MS brain decreases with disease chronicity, Neurology, 72, 1914, 10.1212/WNL.0b013e3181a8260a · DOI · Paper page
  32. Gruchot, 2019, The molecular basis for remyelination failure in multiple sclerosis, Cells, 8, 825, 10.3390/cells8080825 · DOI
  33. Haghikia, 2012, Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study, Neurology, 79, 2166, 10.1212/WNL.0b013e3182759621 · DOI
  34. Hart, 2012, Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences, Brain Behav. Immun., 26, 754, 10.1016/j.bbi.2011.11.006 · DOI · Paper page
  35. Hemond, 2019, MRI phenotypes in MS: longitudinal changes and miRNA signatures, Neurol Neuroimmunol Neuroinflamm, 6, e530, 10.1212/NXI.0000000000000530 · DOI
  36. Hiebert, 2015, Traumatic brain injury and mitochondrial dysfunction, Am J Med Sci, 350, 132, 10.1097/MAJ.0000000000000506 · DOI
  37. Huang, 2012, Chapter 12 - Current status of myelin replacement therapies in multiple sclerosis, 219
  38. Jia, 2021, New insights into targeting mitochondria in ischemic injury, Apoptosis, 26, 163, 10.1007/s10495-021-01661-5 · DOI
  39. Jolanda Münzel, 2013, Promoting remyelination in multiple sclerosis—recent advances, Drugs, 73, 2017, 10.1007/s40265-013-0146-8 · DOI
  40. Kamma, 2022, Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics, J. Neuroinflammation, 19, 45, 10.1186/s12974-022-02408-y · DOI
  41. Koch, 2015, Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis, J. Neurol. Sci., 358, 131, 10.1016/j.jns.2015.08.1525 · DOI
  42. Kremer, 2019, Current advancements in promoting remyelination in multiple sclerosis, Mult. Scler., 25, 7, 10.1177/1352458518800827 · DOI
  43. Kremer, 2015, Promoting remyelination in multiple sclerosis: current drugs and future prospects, Mult. Scler., 21, 541, 10.1177/1352458514566419 · DOI
  44. Kuhlmann, 2008, Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis, Brain, 131, 1749, 10.1093/brain/awn096 · DOI · Paper page
  45. Kuypers, 2016, Remyelinating oligodendrocyte precursor cell miRNAs from the Sfmbt2 cluster promote cell cycle arrest and differentiation, J. Neurosci., 36, 1698, 10.1523/JNEUROSCI.1240-15.2016 · DOI
  46. Ladak, 2019, A review of the molecular mechanisms of traumatic brain injury, World Neurosurg., 131, 126, 10.1016/j.wneu.2019.07.039 · DOI
  47. Lassmann, 2017, Multiple sclerosis: experimental models and reality, Acta Neuropathol., 133, 223, 10.1007/s00401-016-1631-4 · DOI · Paper page
  48. Lecca, 2016, MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis, Sci. Rep., 6, 34503, 10.1038/srep34503 · DOI
  49. Letzen, 2010, MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells, PLoS One, 5, e10480, 10.1371/journal.pone.0010480 · DOI · Paper page
  50. Lewkowicz, 2015, Dysregulated RNA-induced silencing complex (RISC) assembly within CNS corresponds with abnormal miRNA expression during autoimmune demyelination, J. Neurosci., 35, 7521, 10.1523/JNEUROSCI.4794-14.2015 · DOI
  51. Li, 2022, M2 microglia-derived extracellular vesicles promote white matter repair and functional recovery via miR-23a-5p after cerebral ischemia in mice, Theranostics, 12, 3553, 10.7150/thno.68895 · DOI · Paper page
  52. Lin, 2009, miR-23 regulation of lamin B1 is crucial for oligodendrocyte development and myelination, Dis. Model. Mech., 2, 178, 10.1242/dmm.001065 · DOI
  53. Lindner, 2008, Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination, Neuropathol. Appl. Neurobiol., 34, 105, 10.1111/j.1365-2990.2007.00879.x · DOI · Paper page
  54. Liu, 2017, MicroRNA-146a promotes oligodendrogenesis in stroke, Mol. Neurobiol., 54, 227, 10.1007/s12035-015-9655-7 · DOI · Paper page
  55. Liu, 2013, Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil, PLoS One, 8, e54841, 10.1371/journal.pone.0054841 · DOI
  56. Lopaisankrit, 2023, Brain and spinal cord MRI findings in thai multiple sclerosis patients, J. Imaging, 9, 27, 10.3390/jimaging9020027 · DOI
  57. Loulier, 2006, Increase of proliferating oligodendroglial progenitors in the adult mouse brain upon Sonic hedgehog delivery in the lateral ventricle, J. Neurochem., 98, 530, 10.1111/j.1471-4159.2006.03896.x · DOI
  58. Lucchinetti, 1999, A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases, Brain, 122, 2279, 10.1093/brain/122.12.2279 · DOI · Paper page
  59. Marangon, 2020, In vivo silencing of miR-125a-3p promotes myelin repair in models of white matter demyelination, Glia, 68, 2001, 10.1002/glia.23819 · DOI
  60. Mason, 2000, Insulin-like growth Factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination, J. Neurosci., 20, 5703, 10.1523/JNEUROSCI.20-15-05703.2000 · DOI · Paper page
  61. Mazloumfard, 2020, Hydroxychloroquine effects on miR-155-3p and miR-219 expression changes in animal model of multiple sclerosis, Metab. Brain Dis., 35, 1299, 10.1007/s11011-020-00609-z · DOI · Paper page
  62. McCoy, 2017, miR-155 dysregulation and therapeutic intervention in multiple sclerosis, Adv. Exp. Med. Biol., 1024, 111, 10.1007/978-981-10-5987-2_5 · DOI · Paper page
  63. Medina-Rodríguez, 2017, Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for multiple sclerosis, Sci. Rep., 7, 43545, 10.1038/srep43545 · DOI
  64. Mi, 2005, LINGO-1 negatively regulates myelination by oligodendrocytes, Nat. Neurosci., 8, 745, 10.1038/nn1460 · DOI
  65. Milbreta, 2019, Scaffold-mediated sustained, non-viral delivery of miR-219/miR-338 promotes CNS remyelination, Mol. Ther., 27, 411, 10.1016/j.ymthe.2018.11.016 · DOI
  66. Moody, 2017, Methods and novel technology for microRNA quantification in colorectal cancer screening, Clin. Epigenetics, 9, 119, 10.1186/s13148-017-0420-9 · DOI · Paper page
  67. Morris, 2015, Decrease in levels of the evolutionarily conserved microRNA miR-124 affects oligodendrocyte numbers in zebrafish, Danio rerio, Invert. Neurosci., 15, 4, 10.1007/s10158-015-0180-1 · DOI
  68. Muñoz-San Martín, 2019, Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions, J. Neuroinflammation, 16, 220, 10.1186/s12974-019-1590-5 · DOI
  69. Neumann, 2017, Remyelination of regenerating axons, Acta Ophthalmol., 95, 10.1111/j.1755-3768.2017.03525 · DOI
  70. Nguyen, 2019, Effects of miR-219/miR-338 on microglia and astrocyte behaviors and astrocyte-oligodendrocyte precursor cell interactions, Neural Regen. Res., 15, 739, 10.4103/1673-5374.266922 · DOI
  71. Osorio-Querejeta, 2020, MiR-219a-5p enriched extracellular vesicles induce OPC differentiation and EAE improvement more efficiently than liposomes and polymeric nanoparticles, Pharmaceutics, 12, 186, 10.3390/pharmaceutics12020186 · DOI · Paper page
  72. Otero-Ortega, 2017, White matter repair after extracellular vesicles administration in an experimental animal model of subcortical stroke, Sci. Rep., 7, 44433, 10.1038/srep44433 · DOI
  73. Patrikios, 2006, Remyelination is extensive in a subset of multiple sclerosis patients, Brain, 129, 3165, 10.1093/brain/awl217 · DOI · Paper page
  74. Pedersen, 2000, Exercise and the immune system: regulation, integration, and adaptation, Physiol. Rev., 80, 1055, 10.1152/physrev.2000.80.3.1055 · DOI · Paper page
  75. Pennati, 2020, Regulatory B cells normalize CNS myeloid cell content in a mouse model of multiple sclerosis and promote oligodendrogenesis and remyelination, J. Neurosci., 40, 5105, 10.1523/JNEUROSCI.2840-19.2020 · DOI
  76. Piatek, 2019, MS CD49d+CD154+ lymphocytes reprogram oligodendrocytes into immune reactive cells affecting CNS regeneration, Cells, 8, 1508, 10.3390/cells8121508 · DOI
  77. Piatek, 2020, Multiple sclerosis CD49d+CD154+ as myelin-specific lymphocytes induced during remyelination, Cells, 9, 15, 10.3390/cells9010015 · DOI
  78. Piket, 2019, Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: a comprehensive overview, J. Autoimmun., 101, 17, 10.1016/j.jaut.2019.04.002 · DOI · Paper page
  79. Pusic, 2014, Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination, Glia, 62, 284, 10.1002/glia.22606 · DOI
  80. Pusic, 2016, Environmental enrichment stimulates immune cell secretion of exosomes that promote CNS myelination and may regulate inflammation, Cell. Mol. Neurobiol., 36, 313, 10.1007/s10571-015-0269-4 · DOI
  81. Qin, 2022, Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions, Sig. Transduct. Target Ther., 7, 215, 10.1038/s41392-022-01064-1 · DOI
  82. Ransohoff, 2012, Animal models of multiple sclerosis: the good, the bad and the bottom line, Nat. Neurosci., 15, 1074, 10.1038/nn.3168 · DOI · Paper page
  83. Ray, 2002, Molecular mechanisms in the pathogenesis of traumatic brain injury, Histol. Histopathol., 17, 1137, 10.14670/HH-17.1137 · DOI
  84. Regev, 2018, Identification of MS-specific serum miRNAs in an international multicenter study, Neurol Neuroimmunol. Neuroinflamm., 5, e491, 10.1212/NXI.0000000000000491 · DOI
  85. Regev, 2016, Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis, Neurol Neuroimmunol. Neuroinflamm., 3, e267, 10.1212/NXI.0000000000000267 · DOI
  86. Schmitz, 2008, Cytokines and myelination in the central nervous system, ScientificWorldJournal, 8, 1119, 10.1100/tsw.2008.140 · DOI
  87. Selmaj, 2017, Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis, Ann. Neurol., 81, 703, 10.1002/ana.24931 · DOI
  88. Sheinerman, 2017, Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases, Alzheimers Res. Ther., 9, 89, 10.1186/s13195-017-0316-0 · DOI · Paper page
  89. Shin, 2009, Dicer ablation in oligodendrocytes provokes neuronal impairment in mice, Ann. Neurol., 66, 843, 10.1002/ana.21927 · DOI
  90. Song, 2017, Biodegradable and biocompatible cationic polymer delivering microRNA-221/222 promotes nerve regeneration after sciatic nerve crush, Int. J. Nanomedicine, 12, 4195, 10.2147/IJN.S132190 · DOI
  91. Stolt, 2003, The Sox9 transcription factor determines glial fate choice in the developing spinal cord, Genes Dev., 17, 1677, 10.1101/gad.259003 · DOI · Paper page
  92. Stolt, 2002, Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10, Genes Dev., 16, 165, 10.1101/gad.215802 · DOI
  93. Stolt, 2006, SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function, Dev. Cell, 11, 697, 10.1016/j.devcel.2006.08.011 · DOI · Paper page
  94. Swanson, 2019, The NLRP3 inflammasome: molecular activation and regulation to therapeutics, Nat. Rev. Immunol., 19, 477, 10.1038/s41577-019-0165-0 · DOI · Paper page
  95. Tepavčević, 2022, Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?, Brain, 145, 4178, 10.1093/brain/awac307 · DOI
  96. Tripathi, 2019, Oligodendrocyte intrinsic miR-27a controls myelination and remyelination, Cell Rep., 29, 904, 10.1016/j.celrep.2019.09.020 · DOI
  97. Uchida, 2012, Human neural stem cells induce functional myelination in mice with severe dysmyelination, Sci. Transl. Med., 4, 155ra136, 10.1126/scitranslmed.3004371 · DOI
  98. Uyeda, 2020, Molecular mechanisms of central nervous system axonal regeneration and remyelination: a review, Int. J. Mol. Sci., 21, 8116, 10.3390/ijms21218116 · DOI
  99. Valério-Gomes, 2018, The absolute number of oligodendrocytes in the adult mouse brain, Front. Neuroanat., 12, 90, 10.3389/fnana.2018.00090 · DOI
  100. van Langelaar, 2020, B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers, Front. Immunol., 11, 760, 10.3389/fimmu.2020.00760 · DOI
  101. Vistbakka, 2018, Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients, Acta Neurol. Scand., 138, 130, 10.1111/ane.12921 · DOI
  102. Wang, 2017, MicroRNA-212 inhibits oligodendrocytes during maturation by down-regulation of differentiation-associated gene expression, J. Neurochem., 143, 112, 10.1111/jnc.14138 · DOI
  103. Wang, 1998, Notch receptor activation inhibits oligodendrocyte differentiation, Neuron, 21, 63, 10.1016/s0896-6273(00)80515-2 · DOI
  104. Wiggermann, 2023, Quantitative magnetic resonance imaging reflects different levels of histologically determined myelin densities in multiple sclerosis, including remyelination in inactive multiple sclerosis lesions, Brain Pathol., e13150, 10.1111/bpa.13150 · DOI
  105. Wittstatt, 2020, MicroRNA miR-204 regulates proliferation and differentiation of oligodendroglia in culture, Glia, 68, 2015, 10.1002/glia.23821 · DOI
  106. Wlodarczyk, 2017, A novel microglial subset plays a key role in myelinogenesis in developing brain, EMBO J., 36, 3292, 10.15252/embj.201696056 · DOI · Paper page
  107. Woodruff, 2004, Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination, Mol. Cell. Neurosci., 25, 252, 10.1016/j.mcn.2003.10.014 · DOI · Paper page
  108. Xiao, 2019, Bone marrow-derived mesenchymal stem cells-derived exosomes prevent oligodendrocyte apoptosis through exosomal miR-134 by targeting caspase-8, J. Cell. Biochem., 120, 2109, 10.1002/jcb.27519 · DOI
  109. Zhao, 2010, MicroRNA-mediated control of oligodendrocyte differentiation, Neuron, 65, 612, 10.1016/j.neuron.2010.02.018 · DOI · Paper page
  110. Zheng, 2018, Propofol attenuates inflammatory response in LPS-activated microglia by regulating the miR-155/SOCS1 pathway, Inflammation, 41, 11, 10.1007/s10753-017-0658-6 · DOI
  111. Zurawska, 2019, Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis, J. Neuroimmunol., 334, 576971, 10.1016/j.jneuroim.2019.576971 · DOI

Cited by

Sorted by citations

Metadata

Authors
Maciak, K., Dziedzic, A., & Saluk, J.
Venue
Frontiers in Molecular Neuroscience
Publisher
Frontiers Media SA
Published
2023-06-01
Volume
16
ISSN
1662-5099
DOI
10.3389/fnmol.2023.1199313
PMC
PMC10270307
Cited by
28
References
10
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review